Company Search:
Advanced Search
Sponsored Links
Revance Therapeutics Inc Company Snapshot
Revance Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Revance Therapeutics Inc with three other companies in this sector in the United States: Aytu Bioscience Inc (2018 sales of $3.66 million of which 93% was Aytu), Starpharma Holdings Limited ($3.83 million of which 100% was Dendritic), and X4 Pharmaceuticals Inc ($3.50 million of which 100% was Biological Products).

Sales Analysis. Sales increased substantially in 2018: Revance Therapeutics Inc reported sales of $3.73 million for the year ending December of 2018. This represents an increase of 1,323.3% versus 2017, when the company's sales were $262,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Revance Therapeutics Inc
  Stock Performance Chart for Revance Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 15.81
(Figures in U.S. Dollars)
1 Week 2.0%   13 Weeks 4.2%  
4 Weeks 39.4%   52 Weeks -24.7%  
Revance Therapeutics Inc Key Data:
  Ticker: RVNC Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,729,000
(Year Ending Jan 2019).
Employees: 170
  Currency: U.S. Dollars Market Cap: 697,353,915
  Fiscal Yr Ends: December Shares Outstanding: 44,108,407
  Share Type: Common Closely Held Shares: 1,997,206
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.